Bottom line
How much do BBP and PBE overlap?
16% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 8.3% of BBP's assets and 17.9% of PBE's. They are substantially different portfolios, so owning both adds real diversification.
BBP holds far more positions (70 vs 33), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings BBP and PBE have in common
| Holding | % of BBP | % of PBE | Overlap |
|---|---|---|---|
| Regeneron Pharmaceuticals REGN | 1.72% | 5.47% | 1.72% |
| Protagonist Therapeutics Inc PTGX | 1.71% | 3.40% | 1.71% |
| Acadia Pharmaceuticals Inc ACAD | 1.69% | 3.02% | 1.69% |
| Halozyme Therapeutics Inc HALO | 1.64% | 2.98% | 1.64% |
| Incyte Corp INCY | 1.52% | 3.06% | 1.52% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in BBP
- Crinetics Pharmaceuticals Inc — 3.34%
- Kiniksa Pharmaceuticals International Plc — 1.97%
- Verastem Inc — 1.95%
- Precigen Inc — 1.94%
- Omeros Corp — 1.87%
- Nuvation Bio Inc — 1.77%
- Bridgebio Pharma Inc — 1.65%
- Beone Medicines Ltd — 1.65%
- Xeris Biopharma Holdings Inc — 1.64%
- Liquidia Corp — 1.63%
- Immunocore Holdings Plc — 1.61%
- Ironwood Pharmaceuticals Inc — 1.60%
- Arrowhead Pharmaceuticals Inc — 1.56%
- Roivant Sciences Ltd — 1.55%
- Ligand Pharmaceuticals — 1.55%
Only in PBE
- Invesco Private Prime Fund — 12.89%
- Amgen Inc. — 5.22%
- CareDx, Inc. — 5.04%
- Vertex Pharmaceuticals Inc. — 4.99%
- Invesco Private Government Fund — 4.97%
- Royalty Pharma PLC — 4.94%
- Biogen Inc. — 4.79%
- Gilead Sciences, Inc. — 4.43%
- United Therapeutics Corp. — 4.08%
- Bio-Techne Corp. — 3.73%
- Illumina, Inc. — 3.51%
- Vericel Corp. — 3.27%
- Alnylam Pharmaceuticals, Inc. — 3.17%
- Repligen Corp. — 3.04%
- Qiagen N.V. — 2.89%
Asset mix
| Asset type | BBP | PBE |
|---|---|---|
| Stocks | 99.8% | 100.1% |
| Cash & short-term funds | 0.7% | 17.9% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | BBP | PBE |
|---|---|---|
| US | 84.6% | 108.6% |
| GB | 3.6% | 4.9% |
| KY | 3.6% | 1.6% |
| CH | 3.0% | — |
| NL | — | 2.9% |
| BM | 1.6% | — |
| DK | 1.5% | — |
| DE | 1.4% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do BBP and PBE overlap?
What stocks do BBP and PBE have in common?
Should I own both BBP and PBE?
Which holds more stocks, BBP or PBE?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.